Craig A. H Richard, Ph. D. , Carolyn J Kubik, M. D

Slides:

Advertisements

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Advertisements

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? Micah.

Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? Matthew.

Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation Renato.

Evaluation of basal estradiol levels in assisted reproductive technology cycles2 John L Frattarelli, M.D., Paul A Bergh, M.D., Michael R Drews, M.D.,

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Obstetric and perinatal outcomes after either fresh or thawed frozen embryo transfer: an analysis of 112,432 singleton pregnancies recorded in the Human.

Measurement of inhibin A and inhibin pro-αC in early human pregnancy and their role in the prediction of pregnancy outcome in patients with recurrent.

Human chorionic gonadotropin ratio of hemoperitoneum versus venous serum improves early diagnosis of ectopic pregnancy YuDong Wang, M.D., Hong Zhao,

Early loss rates of entire pregnancies after assisted reproduction are lower in twin than in singleton pregnancies Alexandra Matias, M.D., Giovanni B.

Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Ewa Nowak-Markwitz,

The impact of total gonadotropin dose on spontaneous abortion rates and early pregnancy outcomes in infertile couples undergoing gonadotropin induction/intrauterine.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization–embryo.

Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies Gillian Homan, Susan Brown, R.N., John Moran,

Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle James R. Stelling, M.D., Emily.

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity Katherine.

Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc

Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort.

Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review Seema Menon, M.D., John.

Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T

Robert F. Casper, M.D. Fertility and Sterility

Association of the very early rise of human chorionic gonadotropin with adverse outcomes in singleton pregnancies after in vitro fertilization Christopher.

Success of intrauterine insemination in women aged 40–42 years

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

Early pregnancy losses in in vitro fertilization and oocyte donation

Are serum human chorionic gonadotropin clearance curves of use in monitoring methotrexate treatment in cervical pregnancy? Petra J. Hajenius, M.D., Daphne.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Dmitry M. Kissin, M. D. , M. P. H. , Jennifer F. Kawwass, M. D

Human chorionic gonadotropin levels after blastocyst transfer are highly predictive of pregnancy outcome1 Theocharis C Papageorgiou, M.D., Mark P Leondires,

Mark D Hornstein, M. D. , Owen K Davis, M. D. , Joe B Massey, M. D

Early serum β-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term.

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model Robin H. Fogle,

Frequency and effect of vaginal bleeding on pregnancy outcome during the first 3 weeks after positive β-hCG test results following IVF-ET Glen E Hofmann,

Pete N. Lohstroh, B. S. , James W. Overstreet, M. D. , Ph. D

Comparison of two methods for the measurement of sperm concentration

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

Association between birth weight and first-trimester free β–human chorionic gonadotropin and pregnancy-associated plasma protein A Silvana Canini, B.Sc.,

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Difference between serum beta-human chorionic gonadotropin levels in pregnancies after in vitro maturation and in vitro fertilization treatments Benny.

Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D

Atsushi Yanaihara, M. D. , Ph. D. , Takeshi Yorimitsu, M. D

Regulation of assisted reproductive technologies in the United States

Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Luis.

Apichart Chittacharoen, M.D., Yongyoth Herabutya, F.R.C.O.G.

Absence of corpus luteum rescue by chorionic gonadotropin in women immunized with a contraceptive vaccine Rahul Pal, Ph.D., Om Singh, Ph.D. Fertility.

Kayoko Takata, M. D. , Nobuhiko Suganuma, M. D. , Hisae Wada, M. D

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization David W. Schmidt, M.D.,,

Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro.

Upregulation of mRNA expression of vascular endothelial growth factor and its receptors by exogenous human chorionic gonadotropin in cultured oviduct.

Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies Pete N. Lohstroh, Ph.D, James W.

Marcia A Ellison, PhD, Janet E Hall, MD Fertility and Sterility

Use of serum inhibin A and human chorionic gonadotropin measurements to predict the outcome of in vitro fertilization pregnancies Erik Hauzman, M.D.,

Effects of exogenous estrogen on uterine leukocyte recruitment

Day 3 morphology is a poor predictor of blastocyst quality in extended culture James Graham, M.S., Taer Han, B.S., Richard Porter, Michael Levy, M.D.,

Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following.

Increased pregnancy rates after ultralong postoperative therapy with gonadotropin- releasing hormone analogs in patients with endometriosis Dagmar Rickes,

Peter M. Martin, M.D., H.Gilbert Welch, M.D. Fertility and Sterility

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles

Use of recombinant human chorionic gonadotropin in ovulation induction

Multifetal pregnancy in older women and perinatal outcomes

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:

Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization Sandy Chuan, M.D., Michael Homer,

Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles John L. Frattarelli,

Presentation transcript:

Physiological range of human chorionic gonadotropin for support of early human pregnancy Craig A.H Richard, Ph.D., Carolyn J Kubik, M.D., Julie A DeLoia, Ph.D. Fertility and Sterility Volume 76, Issue 5, Pages 988-993 (November 2001) DOI: 10.1016/S0015-0282(01)02864-3

Figure 1 A scattergram distribution of all the hCG values for days 12–16 post-OR for successful singleton birth outcomes. Numbers in parentheses are the highest and lowest values for each day. Richard. Early pregnancy range of hCG. Fertil Steril 2001. Fertility and Sterility 2001 76, 988-993DOI: (10.1016/S0015-0282(01)02864-3)

Figure 2 Highest and lowest quartile mean values for days 12–16 post-OR. Displayed error bars are SDs. Mean values of all data points for each day are shown for reference and comparison. Richard. Early pregnancy range of hCG. Fertil Steril 2001. Fertility and Sterility 2001 76, 988-993DOI: (10.1016/S0015-0282(01)02864-3)

Figure 3 Scattergram distribution displaying the range of doubling times for the 48-hour periods during days 12–14, days 13–15, and days 14–16. The highest and lowest values for each 48-hour data set are displayed in parentheses. Underlined values are mean values for each 48-hour data set, and location of mean is indicated by bar symbol. Richard. Early pregnancy range of hCG. Fertil Steril 2001. Fertility and Sterility 2001 76, 988-993DOI: (10.1016/S0015-0282(01)02864-3)